Bracco Imaging SpA

Bracco Imaging SpA is a company in Milano, Italy that has taken part in 6 EU-funded projects since 2013, receiving €2.3M in EU funding.

EU funding received€2.3M
EU projects6
As coordinator0
Running now2
First EU project2013
Latest project2024
CountryItaly
EU registration (PIC)997807767
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bracco Imaging SpA's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€816k · 1 project
  • Horizon Europe€759k · 2 projects
  • Horizon 2020€737k · 3 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • ILLUMINATEPartner

    INCREASING LUTETIUM PRODUCTION, WHILE LEVERAGING METABOLIC IMAGING TO ENHANCE THERANOSTICS EFFECTIVENESS

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €500ktheir share
  • FC-RELAXPartner

    NMR relaxometry for biomedicine and advanced materials

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €259ktheir share
  • INCIPITPartner

    INnovative Life sCIence Phd Programme in South ITaly

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

  • GLINTPartner

    GlucoCEST Imaging of Neoplastic Tumours

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €645ktheir share
  • SPCCTPartner

    In Vivo Spectral Photon Counting CT Molecular Imaging in Cardio- and Neuro-Vascular Diseases

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €91ktheir share
  • NANOATHEROPartner

    Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €816ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • arteriosclerosis
  • breast cancer
  • computed tomography
  • diagnostic imaging
  • drug discovery
  • inorganic chemistry
  • magnetic resonance imaging
  • molecular and chemical physics
  • nano-materials
  • nanomedicine
  • nuclear medicine
  • pharmacokinetics
  • photons
  • post-transition metals

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime